134 related articles for article (PubMed ID: 2648025)
21. A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
Shepardson K; Larson K; Cho H; Johns LL; Malkoc Z; Stanek K; Wellhman J; Zaiser S; Daggs-Olson J; Moodie T; Klonoski JM; Huber VC; Rynda-Apple A
Viral Immunol; 2019 Apr; 32(3):131-143. PubMed ID: 30822217
[TBL] [Abstract][Full Text] [Related]
22. Neddylation of M1 negatively regulates the replication of influenza A virus.
Li Y; Chai W; Min J; Ye Z; Tong X; Qi D; Liu W; Luo E; Li J; Ye X
J Gen Virol; 2020 Dec; 101(12):1242-1250. PubMed ID: 33016861
[TBL] [Abstract][Full Text] [Related]
23. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.
Stitz L; Schmitz C; Binder D; Zinkernagel R; Paoletti E; Becht H
J Gen Virol; 1990 May; 71 ( Pt 5)():1169-79. PubMed ID: 1693165
[TBL] [Abstract][Full Text] [Related]
24. Influenza virus: association of mouse-lung virulence with plaque formation in mouse kidney cells.
Flehmig B; Vallbracht A; Gerth HJ
Intervirology; 1976; 7(4-5):201-10. PubMed ID: 1010711
[TBL] [Abstract][Full Text] [Related]
25. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.
Mitnaul LJ; Matrosovich MN; Castrucci MR; Tuzikov AB; Bovin NV; Kobasa D; Kawaoka Y
J Virol; 2000 Jul; 74(13):6015-20. PubMed ID: 10846083
[TBL] [Abstract][Full Text] [Related]
26. Location of influenza virus M, NP and NS1 proteins in microinjected cells.
Davey J; Colman A; Dimmock NJ
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2319-34. PubMed ID: 2932535
[TBL] [Abstract][Full Text] [Related]
27. A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site.
Gubareva LV; Nedyalkova MS; Novikov DV; Murti KG; Hoffmann E; Hayden FG
J Gen Virol; 2002 Nov; 83(Pt 11):2683-2692. PubMed ID: 12388803
[TBL] [Abstract][Full Text] [Related]
28. A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.
De Baets S; Verhelst J; Van den Hoecke S; Smet A; Schotsaert M; Job ER; Roose K; Schepens B; Fiers W; Saelens X
PLoS One; 2015; 10(3):e0121491. PubMed ID: 25816132
[TBL] [Abstract][Full Text] [Related]
29. In vivo anti-influenza virus activity of kampo (Japanese herbal) medicine "sho-seiryu-to" and its mode of action.
Nagai T; Yamada H
Int J Immunopharmacol; 1994 Aug; 16(8):605-13. PubMed ID: 7527377
[TBL] [Abstract][Full Text] [Related]
30. Virions and intracellular nucleocapsids produced during mixed heterotypic influenza infection of MDCK cells.
Sklyanskaya EI; Varich NL; Amvrosieva TV; Kaverin NV
J Virol; 1985 Feb; 53(2):679-83. PubMed ID: 4038521
[TBL] [Abstract][Full Text] [Related]
31. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
32. [Preparation and identification of monoclonal antibody against H1N1 influenza virus].
Liu Y; Zhao X; Guo C; Li Y; Wang G; Liang D; Yu P; Li Y; Hu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):688-694. PubMed ID: 28502308
[TBL] [Abstract][Full Text] [Related]
33. Neutralization of influenza virus by low concentrations of hemagglutinin-specific polymeric immunoglobulin A inhibits viral fusion activity, but activation of the ribonucleoprotein is also inhibited.
Armstrong SJ; Dimmock NJ
J Virol; 1992 Jun; 66(6):3823-32. PubMed ID: 1583731
[TBL] [Abstract][Full Text] [Related]
34. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 1999 Feb; 17(7-8):653-9. PubMed ID: 10067670
[TBL] [Abstract][Full Text] [Related]
35. Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Zhirnov OP; Klenk HD
Virology; 2009 Nov; 394(1):57-63. PubMed ID: 19747708
[TBL] [Abstract][Full Text] [Related]
36. Properties of host components of PR8 influenza virus.
Arcus YM; Knight CA
Intervirology; 1981; 15(3):171-6. PubMed ID: 7287359
[TBL] [Abstract][Full Text] [Related]
37. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
[TBL] [Abstract][Full Text] [Related]
38. Major contribution of the RNA-binding domain of NS1 in the pathogenicity and replication potential of an avian H7N1 influenza virus in chickens.
Trapp S; Soubieux D; Lidove A; Esnault E; Lion A; Guillory V; Wacquiez A; Kut E; Quéré P; Larcher T; Ledevin M; Nadan V; Camus-Bouclainville C; Marc D
Virol J; 2018 Mar; 15(1):55. PubMed ID: 29587792
[TBL] [Abstract][Full Text] [Related]
39. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells.
Egorov A; Brandt S; Sereinig S; Romanova J; Ferko B; Katinger D; Grassauer A; Alexandrova G; Katinger H; Muster T
J Virol; 1998 Aug; 72(8):6437-41. PubMed ID: 9658085
[TBL] [Abstract][Full Text] [Related]
40. High-density microcarrier cell cultures for influenza virus production.
Bock A; Schulze-Horsel J; Schwarzer J; Rapp E; Genzel Y; Reichl U
Biotechnol Prog; 2011; 27(1):241-50. PubMed ID: 21312371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
